Wojo Nutritionals launches line of liquid supplements

OVERLAND PARK, Kan. — Wojo Nutritionals recently launched a line of single-serve liquid supplements that can be added to any drink.

Each single serving formula begins with a base of six B vitamins. It's then enhanced with a blend of herbal extracts and naturally derived amino acids and vitamins specific to its intended use. As an added health benefit, all Wojo offerings are free of sugar, artificial sweeteners and flavorings, and chemical masking agents.

Currently, there are two products available for purchase. wojoENERGY provides energy while wojoCALM is a soothing way to remove stress. This summer they'll be releasing four new offerings including wojoFOCUS, wojoSUN, wojoWELL and wojoMOOD.

GSK and WebMD join on headache education

PARSIPPANY, N.J. – To kick-off National Headache Month, GlaxoSmithKline and WebMD launched web tools aimed at educating headache sufferers on the condition and, more importantly, how to manage head pain, with new tools and engaging content.

"Here's a situation where the whole is greater than the sum of its parts. By coupling the headache expertise that the makers of Excedrin offer with the timely and trusted health information provided by WebMD, we now have an even more robust offering for headache sufferers everywhere," said Jason Milligan, senior brand manager, Excedrin.

"Millions of consumers turn to WebMD each month to find information about managing headaches and migraines," said Michael Smith, chief medical editor, WebMD. "Both WebMD and the makers of Excedrin have a shared goal of helping consumers to better understand their headache symptoms so they can make more informed decisions about treatment options."

An element of the collaboration includes a survey conducted by WebMD, which shows significant differences between what headache sufferers are doing to treat their pain and what doctors recommend. Findings from the new WebMD survey show that one out of three respondents reports suffering from headaches weekly. According to the survey, 46% of respondents choose to "tough out" their headaches, despite doctor advice. In fact, nine out of 10 physicians suggest not toughing out headaches and eight out of 10 suggest treating headaches early, because there is support for the idea that medications work better when taken at the first sign of a headache.

In addition to key insights from the survey, the following resources are now available:

To help headache and migraine sufferers easily understand which Excedrin product is right for them, the makers of Excedrin developed a Product Selector Tool, available on Excedrin.com. The tool includes a short quiz to help identify the user's symptoms and provides a product recommendation that best suits their needs;

Consumers and healthcare professionals will also have access to headache-related content and tools developed by WebMD's editorial team on WebMD.com/headaches and Medscape.com. These destinations will feature news and articles related to mild to moderate, tension, cluster and migraine headaches and slideshows that depict surprising headache triggers; and

Consumers can access the WebMD Headache Assessments tool, which helps consumer analyze headaches they may experience, and the WebMD Headache Map, which provides content related to possible headache types based on the headache location and frequency.

Thync launches neurosignaling device to either energize or induce calm

LOS GATOS, Calif. — Thync has launched a consumer wearable designed to either energize the user or make them calmer. The neurosignaling device is operated with an accompanying app to deliver Thync Vibes, the company stated.

"Our mission at Thync is to ‘unlimit’ people. Thync brings together innovations in neuroscience and engineering so you can access your own abilities," said Isy Goldwasser, CEO Thync. “Our product will help many people improve and enjoy their life more.”

Based upon research from neuroscientists and engineers from Harvard, MIT, Stanford and Arizona State University, Thync's proprietary technology relies on low levels of pulsed electrical energy to signal specific neural pathways, allowing users to dial up or dial down their stress responses and energy levels.

“Today's fast-paced life requires us to switch situations and change mindsets at increasing speed. Thync helps people find calm and focus throughout your day,” said Jamie Tyler, chief science officer. “Thync is the result of groundbreaking research at some of the best academic institutions, combined with cutting-edge engineering that leverages patented algorithms. This has culminated in today's launch of a device that, for the first time, lets you safely tap into the power of your own mind.”

Based on its intended use in lifestyle applications, the Food and Drug Administration exempted the Thync System from medical device regulations requiring pre-market notification or approval, Thync stated.

RELATED NEWS

Coming toward the end of the calendar year, there will be many consumers perusing purchases of over-the-counter medicines and devices in an effort to deplete their flexible spending accounts, many of which still contain a “use-it-or-lose-it” provision.

Private label just keeps chugging along.
Thanks to strong consumer demand for lower-priced alternatives to national brands and retailer desires to differentiate themselves from the competition, private label seems to keep gaining more traction in the retail world.

In a Journal of Advanced Nursing study of 90 adults with type 2 diabetes published last week, female gender, elevated blood sugar levels, neuropathic pain, and fatigue were related to sleep disturbance, even after controlling for factors such as age, diabetes duration, depressive symptoms and distress.

Ascensia Diabetes Care, based out of Basel, Switzerland, is showing its support for World Diabetes Day 2017 by publishing 30 portraits of inspiring women who are making significant contributions to advancing diabetes care.

Forgotten Password

Registration complete

REGISTER

USERNAME *

Spaces are allowed; punctuation is not allowed except for periods, hyphens, and underscores.

E-MAIL ADDRESS *

A valid e-mail address. All e-mails from the system will be sent to this address. The e-mail address is not made public and will only be used if you wish to receive a new password or wish to receive certain news or notifications by e-mail.

Password *

Confirm Password *

Please choose a password for your account; it must be 8 - 30 characters. .

First Name *

Last Name *

Company Name *

Job Title *

ZIP *

Are you a *

Retailer or Healthcare professional

Non-Retailer

How many stores do you operate?: *

Which best describes the business/industry you work in?: *

Which best describes your job title?: *

Please select the newsletters you would like to subscribe to

DSN A.M.
Daily news stories covering the retail drug industry

Breaking News
First-to-the-market with developing stories in the industry